Today: 12 May 2026
AMD Stock Jumps as Stifel Lifts Price Target to $320 Ahead of May 5 Earnings
22 April 2026
2 mins read

AMD Stock Jumps as Stifel Lifts Price Target to $320 Ahead of May 5 Earnings

NEW YORK, April 22, 2026, 15:11 EDT

Shares of Advanced Micro Devices jumped roughly 6% to $302.24 on Wednesday, following a fresh 12-month price target boost from Stifel. The firm bumped its target up to $320 from $280 while maintaining its Buy call. AMD touched as high as $302.57 during the session, extending a brisk rally for April.

This shift is notable: most of the expected gains from Stifel’s new price target are already priced in. AMD now trades less than 6% below that mark and sits just shy of Bank of America’s $310 target. That puts the spotlight on its first-quarter report due May 5—the next real test.

Chip shares have been tearing higher. According to Reuters, the Philadelphia Semiconductor Index notched a new high and looked headed for its 16th consecutive advance on Wednesday. European semiconductor stocks followed suit, with investors piling in on expectations that AI data-center spending isn’t slowing down.

“AI-driven compute demand continues to run above expectations across both accelerated and general-purpose architectures,” Stifel’s Ruben Roy said, highlighting robust appetite for AI accelerators alongside traditional server chips. Stifel additionally flagged multi-gigawatt commitments from Meta and OpenAI. TheStreet

Those commitments now play a pivotal role in the AMD narrative. Back in February, AMD announced plans to deliver up to 6 gigawatts of GPUs to Meta—graphics chips designed for training and running AI models—with the first gigawatt scheduled to ship in the second half of 2026. Elsewhere in its annual report, AMD cited a separate 6-gigawatt OpenAI deal involving MI450 chips. Meta chief Mark Zuckerberg, for his part, called AMD “an important partner for many years to come.” AMD

AMD wants to turn those deals into something bigger—a direct shot at Nvidia, which still leads the AI chip market. At its November analyst day, CEO Lisa Su called it “a new era of growth.” The company also said its Helios systems, using MI450 GPUs, will start shipping in the third quarter of 2026. Helios brings together chips, networking gear and software in a single rack-scale data center platform. Reuters

Company figures are setting the tone. AMD posted a record $10.3 billion in fourth-quarter 2025 revenue, with data-center sales jumping 39% to $5.4 billion. Looking ahead, the chipmaker expects first-quarter 2026 revenue around $9.8 billion. CEO Lisa Su pointed to “strong momentum” going into 2026, citing gains from EPYC server chips, Ryzen processors, and the data-center AI segment. Advanced Micro Devices, Inc.

Stifel isn’t alone in boosting expectations. Just last week, Bank of America bumped its AMD target up to $310 from $280, arguing that every gigawatt of AI capacity installed might add $15 billion to $20 billion in net revenue for AMD. Bernstein, pointing to stronger server results and the Meta deal, lifted its own target to $265. Shares have already blown past that level.

Still, after such a rally, there’s less margin for error. Stifel pointed to growing supply issues, while AMD’s February guidance signaled a slight sequential decline, with Q1 revenue guidance landing near $9.8 billion. Back then, Bernstein’s Stacy Rasgon said short-term AI figures weren’t really taking off—unless China sales picked up. The Meta and OpenAI deals? Both feature performance-based warrants that could end up diluting current shareholders if AMD hits the required targets.

So, May 5 looms as the next big moment. For AMD, the key: proof that hefty AI spending is actually translating to brisker sales—without any cracks in its server-chip line. Pull that off, and Wall Street’s recent target hikes might stick. If not, the stock, which has already zipped past one analyst’s price and nearly hit another, could see investors take a harder line.

Stock Market Today

  • Wall Street Slides as AI Stocks Falter and Oil Prices Rise Amid Iran Conflict
    May 12, 2026, 5:23 PM EDT. Wall Street paused its record-setting rally as AI stocks declined and oil prices climbed amid tensions with Iran. The S&P 500 dropped 0.2% from its previous high, while the Nasdaq slipped 0.7%. Dow Jones Industrial Average rose slightly by 56 points. Significant losses hit chipmakers: Intel fell 6.8%, Micron Technology 3.6%, trimming strong year-to-date gains. South Korea's Kospi also dropped 2.3%, spooked by potential AI profit redistribution. Brent crude surged 3.4% to $107.77 a barrel due to Strait of Hormuz restrictions from the Iran war. Rising oil costs worsened U.S. inflation, surpassing forecasts, with Treasury yields climbing to 4.45%. Investors anticipate the Federal Reserve may maintain or hike interest rates amid persistent inflation concerns.

Latest article

Tesla Stock Falls as Hot Inflation and Robotaxi Doubts Test the AI Premium

Tesla Stock Falls as Hot Inflation and Robotaxi Doubts Test the AI Premium

12 May 2026
Tesla shares fell 2.7% to $433.45 after U.S. inflation data pushed Treasury yields higher and Reuters reported long waits and spotty robotaxi service in Texas. The stock swung from a high of $447.56 to a low of $422.39. Tesla’s valuation remains near $1.53 trillion, with a price-to-earnings ratio close to 398. Management cited cautious robotaxi rollout and increased 2026 capital spending above $25 billion.
Ernexa Stock’s 58% Jump Shows How Fast a Tiny Biotech Can Reprice on Ovarian-Cancer Hopes

Ernexa Stock’s 58% Jump Shows How Fast a Tiny Biotech Can Reprice on Ovarian-Cancer Hopes

12 May 2026
Ernexa Therapeutics shares jumped 58.5% to $11.43 Tuesday after renewed investor focus on its preclinical ovarian-cancer therapy ERNA-101, following a May 11 investor event. Trading volume reached about 18.85 million shares. The company reported $8.3 million in cash as of April 30, less than needed for its 12-month plan, and may use an at-the-market stock sale to raise funds.
UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

12 May 2026
UnitedHealth shares climbed 3.1% to $396.45 Tuesday after unveiling a new Optum Rx fee-based pricing model and raising 2026 profit guidance. The company reported Q1 revenue of $111.7 billion and adjusted earnings of $7.23 per share. Management said fundamentals are improving but described the turnaround as ongoing. Investors responded to both the PBM overhaul and stronger earnings outlook.
Microsoft Stock’s $500 Question: Why Wall Street Is Watching Azure Before Earnings
Previous Story

Microsoft Stock’s $500 Question: Why Wall Street Is Watching Azure Before Earnings

ASML Says It Can Keep Up With AI Chip Boom in 2026, but China Curbs Still Loom
Next Story

ASML Says It Can Keep Up With AI Chip Boom in 2026, but China Curbs Still Loom

Go toTop